Items where Author is "Shepstone, Lee"

Number of items: 6.
Article
  • Cost-effectiveness of mirtazapine for agitated behaviors in dementia:findings from a randomized controlled trial. (2022) Henderson, Catherine and Knapp, Martin and Stirling, Susan and Shepstone, Lee and High, Juliet and Ballard, Clive and Bentham, Peter and Burns, Alistair and Farina, Nicolas and Fox, Chris and Fountain, Julia and Francis, Paul and Howard, Robert and Leroi, Iracema and Livingston, Gill and Nilforooshan, Ramin and Nurock, Shirley and O’brien, John T. and Price, Annabel and Swart, Ann Marie and Tabet, Naji and Telling, Tanya and Thomas, Alan J. and Banerjee, Sube picture_as_pdf
  • Enhanced recovery pathway for older people with hip fracture and cognitive impairment in acute hospitals: the PERFECTED research programme including an RCT. Fox, Chris and Hammond, Simon P and Shepstone, Lee and Poland, Fiona and Henderson, Catherine and Backhouse, Tamara and Penhale, Bridget and Donell, Simon and Knapp, Martin and Lewins, Douglas and MacLullich, Alasdair and Patel, Martyn and Sahota, Opinder and Smith, Toby O and Waring, Justin and Cross, Jane L picture_as_pdf
  • PERFECTED enhanced recovery (PERFECT-ER) care versus standard acute care for patients admitted to acute settings with hip fracture identified as experiencing confusion: study protocol for a feasibility cluster randomized controlled trial. Hammond, Simon P. and Cross, Jane L. and Shepstone, Lee and Backhouse, Tamara and Henderson, Catherine and Poland, Fiona and Sims, Erika and MacLullich, Alasdair and Penhale, Bridget and Howard, Robert and Lambert, Nigel and Varley, Anna and Smith, Toby O. and Sahota, Opinder and Donell, Simon and Patel, Martyn and Ballard, Clive and Young, John and Knapp, Martin and Jackson, Stephen and Waring, Justin and Leavey, Nick and Howard, Gregory and Fox, Chris
  • PERFECTED enhanced recovery pathway (PERFECT-ER) versus standard acute hospital care for people after hip fracture surgery who have cognitive impairment:a feasibility cluster randomised controlled trial. Cross, Jane L. and Hammond, Simon P. and Shepstone, Lee and Poland, Fiona and Henderson, Catherine and Backhouse, Tamara and Penhale, Bridget and Donell, Simon and Knapp, Martin and Lewins, Douglas and Maclullich, Alasdair and Patel, Martyn and Sahota, Opinder and Smith, Toby O. and Waring, Justin and Howard, Robert and Ballard, Clive and Fox, Chris picture_as_pdf
  • Study of mirtazapine for agitated behaviours in dementia (SYMBAD):a randomised, double-blind, placebo-controlled trial. Banerjee, Sube and High, Juliet and Stirling, Susan and Shepstone, Lee and Swart, Ann Marie and Telling, Tanya and Henderson, Catherine and Ballard, Clive and Bentham, Peter and Burns, Alistair and Farina, Nicolas and Fox, Chris and Francis, Paul and Howard, Robert and Knapp, Martin and Leroi, Iracema and Livingston, Gill and Nilforooshan, Ramin and Nurock, Shirley and O'Brien, John and Price, Annabel and Thomas, Alan J. and Tabet, Naji picture_as_pdf
  • A pragmatic, multicentre, double-blind, placebo-controlled randomised trial to assess the safety, clinical and cost-effectiveness of mirtazapine and carbamazepine in people with Alzheimer’s disease and agitated behaviours:the HTA-SYMBAD trial. Banerjee, Sube and Farina, Nicolas and Henderson, Catherine and High, Juliet and Stirling, Susan and Shepstone, Lee and Fountain, Julia and Ballard, Clive and Bentham, Peter and Burns, Alistair and Fox, Chris and Francis, Paul and Howard, Robert and Knapp, Martin and Leroi, Iracema and Livingston, Gill and Nilforooshan, Ramin and Nurock, Shirley and O’Brien, John and Price, Annabel and Thomas, Alan J. and Swart, Ann Marie and Telling, Tanya and Tabet, Naji picture_as_pdf